YOU ARE HERE >
MONEYCONTROL >
MARKETS >
PHARMACEUTICALS
> Dividends - Tamilnadu Dadha Pharmaceuticals
Tamilnadu Dadha Pharmaceuticals
BSE: 506903|SECTOR: Pharmaceuticals
Tamilnadu Dadha Pharmaceuticals is not traded in the last 30 days
Tamilnadu Dadha Pharmaceuticals is not listed on NSE
Tamilnadu Dadha Pharmaceuticals has not declared any dividend for the last several years.
* As per the Profit & Loss account
Dividend Declared
| Announcement Date | Effective Date | Dividend Type | Dividend (%) | Remarks |
|---|---|---|---|---|
| Data Not Available For Dividends | ||||
 | ||||
Source : Dion Global Solutions Limited
Quick Links for Tamilnadu Dadha Pharmaceuticals
Related Searches
Tamilnadu Dadha Pharmaceuticals Stock Price, Tamil Dadha Stock Quote, Tamil Dadha Results , Tamil Dadha News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget
| Financial Glossary
|
Message Board |
Moneybhai |
India's Premiere Technology Guide |
History India | Davos
| Wockhardt | Zee Entertainment Enterprises | SREI Infrastructure Finance Limited | National Institute of Design | Ranbaxy Laboratories Limited (ADR) | BSE SENSEX | Vedanta Resources | Airports | Indian Bank | P. Chidambaram
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.